Use App
Trending
News
Earnings
All
DIA
0.48%
SPY
0.10%
QQQ
1.12%
Trending
SHIB
26.53%
DOGE
4.14%
NEAR
0.60%
CRSR
2.28%
PEPE
5.86%
OCUL
1.33%
HPE
0.10%
PI
1.15%
CMCSA
1.71%
LYFT
1.28%
SHIB
26.53%
DOGE
4.14%
NEAR
0.60%
CRSR
2.28%
PEPE
5.86%
OCUL
1.33%
HPE
0.10%
PI
1.15%
CMCSA
1.71%
LYFT
1.28%
Feed
News
Sentiment
Fundamentals
Info
home
Symbol
CTOR
Exchange:
NASDAQ
·
Updated 06:57 PM EDT
CTOR
Citius Oncology Inc.
$0.5622
$0.016
(2.77%)
Today
·
Closed $0.5622
$0.0048
(0.85%)
After Hours
1
,
3
1
7
1
,
3
1
7
Mkt Cap
$52.27M
Vol
55,823.00
Full Chart
Fundamentals
Mkt Cap
$52.27M
Volume
-
52W High
$2.37
52W Low
$0.4912
PE Ratio
-1.21
Avg. Volume
60,543.50
EPS (Annual)
-$0.338
P/B
1.48
Rev/Employee
-
Earnings
-
Advertisement
|
Remove ads.
Latest CTOR News
View
Citius Oncology Reports Nationwide Deployment of LYMPHIR's Broadened Commercial Organization and Expanding Market Adoption
PR Newswire
Citius Oncology Highlights Phase 1 Data in an Investigator-Initiated Study of LYMPHIR (denileukin diftitox-cxdl) in Combination with Pembrolizumab in Recurrent or Refractory Gynecologic Malignancies
PR Newswire
Citius Oncology Announces Presentation of LYMPHIR Phase 1 Combination Study Data at the 2026 American Society of Clinical Oncology Annual Meeting
PR Newswire
Loading...
Top Discussions
HIMS
$HIMS stock is tumbling today, reversing yesterday's rally, even after an FDA panel recommended adding several peptides to the compounding list. Are you buying the dip?
5
6
1.1K votes
SPY
What do you think the S&P 500's ($SPY) return will be next week?
40
88
12K votes
HIMS
The FDA is deciding whether to add peptides to the compounding list, a ruling that could be huge for $HIMS. How do you think it goes?
5
2
524 votes
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile